-
Luke Bilton posted an update in the group
Supply Chain a year ago (edited)
The announcement of the Pharmaceutical Supply Chain Risk Assessment Act is the latest move by the US Senate to reshore manufacturing away from “bad actors” to domestic drug manufacturing.
Yet despite the rhetoric, pharmaceutical trade between the US and China is actually a balanced 2-way relationship.
How much of a priority is reshoring for you?
pharmasource.global
What is the Pharmaceutical Supply Chain Risk Assessment Act – PharmaSource
What is the Pharmaceutical Supply Chain Risk Assessment Act – PharmaSource
Welcome to PharmaSource
Join the global community of outsourcing & procurement professionals from the world’s leading pharma and biotechs:
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups
Sign up for your free membership 
